Literature DB >> 12188011

Hepatitis A seroprevalence in Slovene travellers.

M Socan1, A Kraigher, N Fiser-Marinic.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2001        PMID： 12188011     DOI： 10.1023/a:1016288518902

Source DB:  PubMed          Journal:  Eur J Epidemiol        ISSN： 0393-2990            Impact factor:   8.082


× No keyword cloud information.
  8 in total

1.  The prevalence of hepatitis A antibodies among Israeli travellers and the economic feasibility of screening before vaccination.

Authors:  E Schwartz; D Raveh
Journal:  Int J Epidemiol       Date:  1998-02       Impact factor: 7.196

2.  Hepatitis A shifting epidemiology in Poland and Eastern Europe.

Authors:  J Cianciara
Journal:  Vaccine       Date:  2000-02-18       Impact factor: 3.641

3.  Screening travelers for hepatitis A antibodies: an observational cost-comparison study of vaccine use.

Authors:  K K Lee; J Beyer-Blodget
Journal:  West J Med       Date:  2000-11

4.  Seroprevalence of viral hepatitis A in the Czech Republic.

Authors:  J Beran; P Douda; R Rychlý
Journal:  Eur J Epidemiol       Date:  1999-10       Impact factor: 8.082

Review 5.  History and epidemiology of hepatitis A virus.

Authors:  J L Melnick
Journal:  J Infect Dis       Date:  1995-03       Impact factor: 5.226

6.  Epidemiology of hepatitis A in Mediterranean countries.

Authors:  G Papaevangelou
Journal:  Vaccine       Date:  1992       Impact factor: 3.641

7.  The diverse patterns of hepatitis A epidemiology in the United States-implications for vaccination strategies.

Authors:  B P Bell; C N Shapiro; M J Alter; L A Moyer; F N Judson; K Mottram; M Fleenor; P L Ryder; H S Margolis
Journal:  J Infect Dis       Date:  1998-12       Impact factor: 5.226

8.  Epidemiology and prevention of hepatitis A in travelers.

Authors:  R Steffen; M A Kane; C N Shapiro; N Billo; K J Schoellhorn; P van Damme
Journal:  JAMA       Date:  1994-09-21       Impact factor: 56.272
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.